ARE STATINS EFFECTIVE TO PREVENT FIRST NON-FATAL MYOCARDIAL INFARCTION IN REAL LIFE IN A LOW-RISK COUNTRY? A POPULATION-BASED CASE-REFERENT STUDY USING THE PGRX INFORMATION SYSTEM
Author(s)
Grimaldi-Bensouda L1, Rossignol M2, Khachatryan A3, Abenhaim L31LA-SER, Paris, Paris, France, 2LA-SER Centre for Risk Research Inc., Montreal, Montreal, Canada, 3LA-SER Europe Ltd., London, London, United Kingdom
OBJECTIVES: To assess the impact of real life statin utilization on the risk of first non-fatal myocardial infarction (MI) METHODS: Case-control methodology using the pharmacoepidemiological information system 'PGRx'. Data on comorbidities, risk factors and medications were obtained from medical records and patient telephone interviews. General practices (n=371) and cardiology centres (n=60) across France were employed in the study. Cases were patients with the first MI
Conference/Value in Health Info
2012-11, ISPOR Europe 2012, Berlin, Germany
Value in Health, Vol. 15, No. 7 (November 2012)
Code
PCV13
Topic
Clinical Outcomes
Topic Subcategory
Comparative Effectiveness or Efficacy
Disease
Cardiovascular Disorders